ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Sep 09, 2026
Healthcare
Carta Healthcare Secures $18.25 Million for AI-Powered Clinical Data Solutions
May 7, 2025
Carta Healthcare has raised $18.25 million in Series B1 funding to enhance its AI-driven clinical data abstraction and analytics services, announced in a press release.
Carta Healthcare has secured $18.25 million in Series B1 funding to advance its AI-powered clinical data abstraction and analytics services, announced in a press release. The investment round was led by UPMC Enterprises, with participation from several strategic investors, including MemorialCare Innovation Fund and Rex Health Ventures.
The funding will enable Carta Healthcare to expand its customer base, particularly in the life sciences sector, and enhance its AI-driven solutions that streamline clinical data abstraction. This comes after the company's acquisition of Realyze Intelligence, which uses AI to analyze structured and unstructured data for clinical trials and research studies.
Brent Burns, Executive Vice President at UPMC Enterprises, highlighted the importance of Carta Healthcare's technology in addressing the challenges of clinical data abstraction and patient trial matching. The investment aims to support the company's mission to provide actionable insights that improve patient care and operational efficiency in healthcare systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 26 Nscale Raises $3.36 Billion in Convertible Financing Before IPO Sep 26 Overlord Labs Raises $7.25 Million for Battery Intelligence Chip Sep 25 NewMod Fearn Launches Patent Law Firm After $5.5 Million Raise Sep 25 Chamelio Raises $26 Million for Legal AI Platform Sep 25 Noxtua Raises €100 Million as C.H.Beck Takes Majority StakeMore from Life Sciences
Sep 26 FDA Clears Nutshell Therapeutics' NRF2 Degrader NTS231 Sep 26 Zifo's TLFGenix Named Runner Up in CDISC AI Challenge Sep 26 Connected Health & Safety Association Conference Draws More Than 250 Leaders Sep 26 AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034 Sep 24 Assort Health Expands AI Agents to More Than 1,300 Primary Care ProvidersFree newsletter
AI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Kairon Health Raises $5 Million for AI Care Operations Platform
Sep 15, 2026
Funding
UrgentIQ Raises $15 Million for AI Clinical Workflows
Sep 11, 2026
Funding
Ayble Health Raises $16 Million for Virtual Digestive Care
Sep 16, 2026
Funding
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
Sep 17, 2026
Healthcare
Heidi Raises $340 Million for Health Care AI Expansion
Sep 23, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.